JPWO2021041237A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021041237A5 JPWO2021041237A5 JP2022512349A JP2022512349A JPWO2021041237A5 JP WO2021041237 A5 JPWO2021041237 A5 JP WO2021041237A5 JP 2022512349 A JP2022512349 A JP 2022512349A JP 2022512349 A JP2022512349 A JP 2022512349A JP WO2021041237 A5 JPWO2021041237 A5 JP WO2021041237A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- tautomer
- acceptable salt
- compound
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025034294A JP2025106242A (ja) | 2019-08-23 | 2025-03-05 | 甲状腺ホルモン受容体ベータアゴニスト化合物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962891078P | 2019-08-23 | 2019-08-23 | |
| US62/891,078 | 2019-08-23 | ||
| US202062967943P | 2020-01-30 | 2020-01-30 | |
| US62/967,943 | 2020-01-30 | ||
| PCT/US2020/047467 WO2021041237A1 (en) | 2019-08-23 | 2020-08-21 | Thyroid hormone receptor beta agonist compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025034294A Division JP2025106242A (ja) | 2019-08-23 | 2025-03-05 | 甲状腺ホルモン受容体ベータアゴニスト化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022544714A JP2022544714A (ja) | 2022-10-20 |
| JPWO2021041237A5 true JPWO2021041237A5 (enExample) | 2023-08-28 |
| JP7646632B2 JP7646632B2 (ja) | 2025-03-17 |
Family
ID=74684314
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022512349A Active JP7646632B2 (ja) | 2019-08-23 | 2020-08-21 | 甲状腺ホルモン受容体ベータアゴニスト化合物 |
| JP2025034294A Pending JP2025106242A (ja) | 2019-08-23 | 2025-03-05 | 甲状腺ホルモン受容体ベータアゴニスト化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025034294A Pending JP2025106242A (ja) | 2019-08-23 | 2025-03-05 | 甲状腺ホルモン受容体ベータアゴニスト化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220281849A1 (enExample) |
| EP (1) | EP4017875A4 (enExample) |
| JP (2) | JP7646632B2 (enExample) |
| CN (1) | CN114430743A (enExample) |
| AU (1) | AU2020336272A1 (enExample) |
| CA (1) | CA3154488A1 (enExample) |
| WO (1) | WO2021041237A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111320609A (zh) | 2018-12-13 | 2020-06-23 | 拓臻股份有限公司 | 一种THRβ受体激动剂化合物及其制备方法和用途 |
| FI3965884T3 (fi) | 2019-05-08 | 2025-04-02 | Aligos Therapeutics Inc | Thr-beetan modulaattoreita, joissa on diokso-1,2,4-triatsyylipääryhmä |
| US12398127B2 (en) | 2019-09-12 | 2025-08-26 | Terns Pharmaceuticals, Inc. | Thyroid hormone receptor beta agonist compounds |
| WO2022011120A1 (en) * | 2020-07-10 | 2022-01-13 | Aligos Therapeutics, Inc. | MODULATORS OF THR-β AND METHODS OF USE THEREOF |
| WO2022037617A1 (zh) * | 2020-08-19 | 2022-02-24 | 成都凡诺西生物医药科技有限公司 | 腈代三嗪类衍生物及其制备方法和应用 |
| EP4301357A4 (en) * | 2021-03-03 | 2025-01-22 | Terns Pharmaceuticals, Inc. | Thyroid hormone receptor beta agonist compounds |
| CN117624073A (zh) * | 2021-03-19 | 2024-03-01 | 南京明德新药研发有限公司 | 双环苯酚类化合物及其应用 |
| WO2022242743A1 (zh) * | 2021-05-21 | 2022-11-24 | 深圳微芯生物科技股份有限公司 | 一种杂环化合物及其应用 |
| CN113979963B (zh) * | 2021-12-24 | 2022-03-11 | 凯思凯旭(上海)医药科技有限公司 | 一种作为甲状腺激素β受体激动剂的化合物及其用途 |
| CN116354934A (zh) * | 2021-12-28 | 2023-06-30 | 中国科学院上海药物研究所 | 一类喹啉类化合物及其制备方法、药物组合物和用途 |
| EP4568664A1 (en) | 2023-04-07 | 2025-06-18 | Terns Pharmaceuticals, Inc. | Combination comprising a thr-beta agonist and a glp-1r agonist for use in treating a liver disorder or a cardiometabolic disease |
| CN120923503A (zh) * | 2025-10-10 | 2025-11-11 | 吉斯凯(苏州)制药有限公司 | 具有杂环结构的化合物、THRβ受体激动剂及用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6787652B1 (en) * | 1999-09-30 | 2004-09-07 | Pfizer, Inc. | 6-Azauracil derivatives as thyroid receptor ligands |
| PT1088819E (pt) * | 1999-09-30 | 2005-09-30 | Pfizer Prod Inc | Derivados de 6-azauracilo como lignados de receptores da tiroide |
| GB0015205D0 (en) * | 2000-06-21 | 2000-08-09 | Karobio Ab | Bioisosteric thyroid receptor ligands and method |
| GB0513692D0 (en) * | 2005-07-04 | 2005-08-10 | Karobio Ab | Novel pharmaceutical compositions |
| HRP20100633T1 (hr) * | 2005-07-21 | 2011-01-31 | F. Hoffmann - La Roche Ag | Derivati piridazinona kao agonisti receptora tiroidnih hormona |
| GB0608724D0 (en) * | 2006-05-03 | 2006-06-14 | Karobio Ab | Novel Pharmaceutical Compositions |
| GB0610322D0 (en) * | 2006-05-24 | 2006-07-05 | Karobio Ab | Novel pharmaceutical compositions |
| US8076334B2 (en) * | 2007-09-20 | 2011-12-13 | Hoffmann-La Roche Inc. | Prodrugs of thyroid hormone analogs |
| CA2758894C (en) * | 2009-04-20 | 2013-09-10 | Mitsubishi Tanabe Pharma Corporation | Novel thyroid hormone .beta. receptor agonist |
| MX394463B (es) * | 2016-10-18 | 2025-03-19 | Madrigal Pharmaceuticals Inc | Métodos para tratar trastornos del hígado o trastornos lipídicos con un agonista de thr-beta. |
| EP3725779A4 (en) * | 2018-01-23 | 2021-02-24 | Shenzhen TargetRx, Inc. | SUBSTITUTED PYRIDAZINONE COMPOUND |
| EP3864013A4 (en) * | 2018-10-12 | 2022-09-28 | InventisBio Co., Ltd. | Thyroid hormone receptor agonists |
| CN119431265A (zh) * | 2019-02-21 | 2025-02-14 | 南京瑞捷医药科技有限公司 | 一种作为甲状腺激素受体激动剂的化合物 |
| FI3965884T3 (fi) * | 2019-05-08 | 2025-04-02 | Aligos Therapeutics Inc | Thr-beetan modulaattoreita, joissa on diokso-1,2,4-triatsyylipääryhmä |
-
2020
- 2020-08-21 WO PCT/US2020/047467 patent/WO2021041237A1/en not_active Ceased
- 2020-08-21 CN CN202080066442.XA patent/CN114430743A/zh active Pending
- 2020-08-21 EP EP20856291.8A patent/EP4017875A4/en active Pending
- 2020-08-21 CA CA3154488A patent/CA3154488A1/en active Pending
- 2020-08-21 JP JP2022512349A patent/JP7646632B2/ja active Active
- 2020-08-21 US US17/637,426 patent/US20220281849A1/en active Pending
- 2020-08-21 AU AU2020336272A patent/AU2020336272A1/en active Pending
-
2025
- 2025-03-05 JP JP2025034294A patent/JP2025106242A/ja active Pending